Related references
Note: Only part of the references are listed.Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex
Naoya Nishitani et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
A Whole-Brain Atlas of Inputs to Serotonergic Neurons of the Dorsal and Median Raphe Nuclei
Iskra Pollak Dorocic et al.
NEURON (2014)
Presynaptic Partners of Dorsal Raphe Serotonergic and GABAergic Neurons
Brandon Weissbourd et al.
NEURON (2014)
Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test
Kenichi Fukumoto et al.
PSYCHOPHARMACOLOGY (2014)
Optogenetic modulation of descending prefrontocortical inputs to the dorsal raphe bidirectionally bias socioaffective choices after social defeat
Collin Challis et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques
H. Yamanaka et al.
TRANSLATIONAL PSYCHIATRY (2014)
Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression
Hiroyuki Koike et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine
Michihiko Iijima et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
John H. Krystal et al.
BIOLOGICAL PSYCHIATRY (2013)
Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice
Yukio Ago et al.
NEUROPHARMACOLOGY (2013)
Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats
Hiroyuki Koike et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism
Valentina Gigliucci et al.
PSYCHOPHARMACOLOGY (2013)
Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists
Xavier Lopez-Gil et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
mTOR activation is required for the antidepressant effects of mGluR2/3 blockade
Jason M. Dwyer et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
Hiroyuki Koike et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Differences between mice strains in response to paroxetine in the forced swimming test: Involvement of serotonergic or noradrenergic systems
Yumi Sugimoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists
Hiroyuki Koike et al.
NEUROPHARMACOLOGY (2011)
Rapid decrease in depressive symptoms with an N-methyl-D-aspartate antagonist in ECT-resistant major depression
Lobna Ibrahim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Antidepressant-Like Effects of Medial Prefrontal Cortex Deep Brain Stimulation in Rats
Clement Hamani et al.
BIOLOGICAL PSYCHIATRY (2010)
Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex
Erin R. Hascup et al.
JOURNAL OF NEUROCHEMISTRY (2010)
On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039
Agnieszka Palucha-Poniewiera et al.
PSYCHOPHARMACOLOGY (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Clozapine and haloperidol differently suppress the MK-801-Increased Glutamatergic and Serotonergic transmission in the medial prefrontal cortex of the rat
Xavier Lopez-Gil et al.
NEUROPSYCHOPHARMACOLOGY (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist
J Karasawa et al.
BRAIN RESEARCH (2005)
Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors
N Kawashima et al.
NEUROSCIENCE LETTERS (2005)
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity
S Chaki et al.
NEUROPHARMACOLOGY (2004)
Prefrontal cortical projections to the rat dorsal raphe nucleus:: Ultrastructural features and associations with serotonin and γ-aminobutyric acid neurons
MP Jankowski et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Electrophysiological evidence for convergence of inputs from the medial prefrontal cortex and lateral habenula on single neurons in the dorsal raphe nucleus
V Varga et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
